Adherence to Azathioprine/6-Mercaptopurine in Children and Adolescents with Inflammatory Bowel Diseases: A Multimethod Study
Background. Measurement of the degree of adherence is a key element for the evaluation of treatment efficacy and safety; thus, adherence plays an important role in clinical research and practice. The aim of this study was to investigate medication adherence in children with inflammatory bowel diseas...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Canadian Journal of Gastroenterology and Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2020/9562192 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832566247927054336 |
|---|---|
| author | Mervat M. Alsous Ahmed F. Hawwa Cameron Imrie Andras Szabo Eman Alefishat Rana Abu Farha Mohammad Rwalah Rob Horne James C. McElnay |
| author_facet | Mervat M. Alsous Ahmed F. Hawwa Cameron Imrie Andras Szabo Eman Alefishat Rana Abu Farha Mohammad Rwalah Rob Horne James C. McElnay |
| author_sort | Mervat M. Alsous |
| collection | DOAJ |
| description | Background. Measurement of the degree of adherence is a key element for the evaluation of treatment efficacy and safety; thus, adherence plays an important role in clinical research and practice. The aim of this study was to investigate medication adherence in children with inflammatory bowel disease (IBD) utilizing a multimethod assessment approach. A further aim was to examine factors that can influence adherence within this population. Methods. Medication adherence in 47 children (age range 3 to 17 years) with IBD in three centers in Northern Ireland and Jordan was assessed via subjective (parent and child versions of the Medication Adherence Report Scale (MARS) specific questionnaire) and objective methods, that is, high-performance liquid chromatography (HPLC) determination of the 6-mercaptopurine (6-MP) and azathioprine (AZA) metabolites in packed red blood cell samples taken during a clinic visit. Beliefs about prescribed medicines were also assessed in parents/guardians using the Beliefs about Medicines Questionnaire (BMQ). Results. An overall nonadherence to AZA/6-MP therapy in children with IBD was found to be 36.17% (17 out of 47 patients were classified as nonadherent using at least one of the assessment methods). A total of 41 patients (91.1%) were classified as adherent to AZA or 6-MP using the blood sampling, while adherence rates using the MARS questionnaire completed by children and parents/guardians were 60.6% and 72.7%, respectively. The latter provides a more longitudinal measure of adherence. Child self-reported nonadherence rates were significantly higher than parent/guardian reported rates (p=0.013). Binary logistic regression analysis identified age to be independently predictive of adherence, with adolescents (children aged ≥ 13 years old) more likely to be classified as nonadherent. Regarding the BMQ, when parental/guardian necessity beliefs outweighed concerns, that is, higher scores in the necessity-concern differential (NCD), adolescents were more likely to be classified as adherent. Conclusion. Results provide evidence for ongoing adherence challenges in the paediatric population with IBD. It is recommended that parents/guardians (particularly of older children) and older children themselves, should receive enhanced counselling and education about their prescribed medicines. |
| format | Article |
| id | doaj-art-54cd6debc09748e89cb557abddd31aea |
| institution | Kabale University |
| issn | 2291-2789 2291-2797 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology and Hepatology |
| spelling | doaj-art-54cd6debc09748e89cb557abddd31aea2025-02-03T01:04:41ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972020-01-01202010.1155/2020/95621929562192Adherence to Azathioprine/6-Mercaptopurine in Children and Adolescents with Inflammatory Bowel Diseases: A Multimethod StudyMervat M. Alsous0Ahmed F. Hawwa1Cameron Imrie2Andras Szabo3Eman Alefishat4Rana Abu Farha5Mohammad Rwalah6Rob Horne7James C. McElnay8Clinical and Practice Research Group, School of Pharmacy, Queen’s University Belfast, Belfast, UKClinical and Practice Research Group, School of Pharmacy, Queen’s University Belfast, Belfast, UKAltnagelvin Area Hospital, Northern Ireland, UKRoyal Belfast Hospital for Sick Children, Northern Ireland, UKDepartment of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, The University of Jordan, Amman, JordanDepartment of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, JordanPaediatric Gastroenterology, Queen Rania Hospital for Children, Royal Medical Services, Amman, JordanCentre for Behavioural Medicine, UCL School of Pharmacy, University College London, London, UKClinical and Practice Research Group, School of Pharmacy, Queen’s University Belfast, Belfast, UKBackground. Measurement of the degree of adherence is a key element for the evaluation of treatment efficacy and safety; thus, adherence plays an important role in clinical research and practice. The aim of this study was to investigate medication adherence in children with inflammatory bowel disease (IBD) utilizing a multimethod assessment approach. A further aim was to examine factors that can influence adherence within this population. Methods. Medication adherence in 47 children (age range 3 to 17 years) with IBD in three centers in Northern Ireland and Jordan was assessed via subjective (parent and child versions of the Medication Adherence Report Scale (MARS) specific questionnaire) and objective methods, that is, high-performance liquid chromatography (HPLC) determination of the 6-mercaptopurine (6-MP) and azathioprine (AZA) metabolites in packed red blood cell samples taken during a clinic visit. Beliefs about prescribed medicines were also assessed in parents/guardians using the Beliefs about Medicines Questionnaire (BMQ). Results. An overall nonadherence to AZA/6-MP therapy in children with IBD was found to be 36.17% (17 out of 47 patients were classified as nonadherent using at least one of the assessment methods). A total of 41 patients (91.1%) were classified as adherent to AZA or 6-MP using the blood sampling, while adherence rates using the MARS questionnaire completed by children and parents/guardians were 60.6% and 72.7%, respectively. The latter provides a more longitudinal measure of adherence. Child self-reported nonadherence rates were significantly higher than parent/guardian reported rates (p=0.013). Binary logistic regression analysis identified age to be independently predictive of adherence, with adolescents (children aged ≥ 13 years old) more likely to be classified as nonadherent. Regarding the BMQ, when parental/guardian necessity beliefs outweighed concerns, that is, higher scores in the necessity-concern differential (NCD), adolescents were more likely to be classified as adherent. Conclusion. Results provide evidence for ongoing adherence challenges in the paediatric population with IBD. It is recommended that parents/guardians (particularly of older children) and older children themselves, should receive enhanced counselling and education about their prescribed medicines.http://dx.doi.org/10.1155/2020/9562192 |
| spellingShingle | Mervat M. Alsous Ahmed F. Hawwa Cameron Imrie Andras Szabo Eman Alefishat Rana Abu Farha Mohammad Rwalah Rob Horne James C. McElnay Adherence to Azathioprine/6-Mercaptopurine in Children and Adolescents with Inflammatory Bowel Diseases: A Multimethod Study Canadian Journal of Gastroenterology and Hepatology |
| title | Adherence to Azathioprine/6-Mercaptopurine in Children and Adolescents with Inflammatory Bowel Diseases: A Multimethod Study |
| title_full | Adherence to Azathioprine/6-Mercaptopurine in Children and Adolescents with Inflammatory Bowel Diseases: A Multimethod Study |
| title_fullStr | Adherence to Azathioprine/6-Mercaptopurine in Children and Adolescents with Inflammatory Bowel Diseases: A Multimethod Study |
| title_full_unstemmed | Adherence to Azathioprine/6-Mercaptopurine in Children and Adolescents with Inflammatory Bowel Diseases: A Multimethod Study |
| title_short | Adherence to Azathioprine/6-Mercaptopurine in Children and Adolescents with Inflammatory Bowel Diseases: A Multimethod Study |
| title_sort | adherence to azathioprine 6 mercaptopurine in children and adolescents with inflammatory bowel diseases a multimethod study |
| url | http://dx.doi.org/10.1155/2020/9562192 |
| work_keys_str_mv | AT mervatmalsous adherencetoazathioprine6mercaptopurineinchildrenandadolescentswithinflammatoryboweldiseasesamultimethodstudy AT ahmedfhawwa adherencetoazathioprine6mercaptopurineinchildrenandadolescentswithinflammatoryboweldiseasesamultimethodstudy AT cameronimrie adherencetoazathioprine6mercaptopurineinchildrenandadolescentswithinflammatoryboweldiseasesamultimethodstudy AT andrasszabo adherencetoazathioprine6mercaptopurineinchildrenandadolescentswithinflammatoryboweldiseasesamultimethodstudy AT emanalefishat adherencetoazathioprine6mercaptopurineinchildrenandadolescentswithinflammatoryboweldiseasesamultimethodstudy AT ranaabufarha adherencetoazathioprine6mercaptopurineinchildrenandadolescentswithinflammatoryboweldiseasesamultimethodstudy AT mohammadrwalah adherencetoazathioprine6mercaptopurineinchildrenandadolescentswithinflammatoryboweldiseasesamultimethodstudy AT robhorne adherencetoazathioprine6mercaptopurineinchildrenandadolescentswithinflammatoryboweldiseasesamultimethodstudy AT jamescmcelnay adherencetoazathioprine6mercaptopurineinchildrenandadolescentswithinflammatoryboweldiseasesamultimethodstudy |